De-Risk Your Clinical Trials with AI: From Discovery to Global Deployment
Only Mindpeak provides an end-to-end platform that standardizes patient selection, unlocks hidden spatial insights, and offers an established commercial ecosystem for immediate worldwide market access.
Our Solutions: Turning Biological Complexity into Clinical Certainty
Biomarker Discovery:
Unlock the Spatial Biology
of the TME
The Challenge: Critical spatial insights and cell-to-cell interactions are often lost in manual pathology or buried in complex, script-heavy bioinformatics pipelines.
Multiplexing Analysis Simplified
By combining the speed and precision of the new ZEISS Axioscan 7 Spatial Biology with the code-free, script-free Mindpeak PhenoScout AI, we deliver a fully automated, standardized workflow for mIF image analysis that eliminates manual bottlenecks and ensures high-quality, reproducible results at scale.
Time-saving
Structured results
Code-free, script-free
Find the Unseen Signature
Go beyond standard scoring. peakDiscover extracts deep tissue and cell features across mIF, IHC, and H&E to characterize the Tumor Microenvironment (TME).
Identify novel biomarker signatures and spatial patterns invisible to the human eye to better understand drug mechanism of action.
Access anytime and anywhere
No experts required.
Image to insight. Fast.
Clinical Trial Support:
De-Risk Your Development Path
The Challenge: 70% of clinical trials fail, frequently due to poor patient selection and high inter-reader variability among pathologists.
Precision Patient Selection
Standardize and enhance your trial endpoints with predictive AI. By quantifying biomarker expression beyond human visibility, you eliminate variability in manual reads and uncover more precise patient stratification, ensuring the right patients are enrolled and your therapy’s efficacy is clearly demonstrated.
Standardize Trial Endpoints
Eliminate "Location Bias"
Direct Treatment Prediction
Go-to-Market:
Solve the "Last Mile" of
Global Access
The Challenge: Even the best diagnostic fails if it cannot be easily adopted by local labs or integrated into existing
digital pathology systems.
Immediate Global Scale
Don't let infrastructure be your barrier to entry. With 18+ IMS partner integrations and presence in 40+ labs worldwide, Mindpeak provides an "instant-on" commercial ecosystem.
Identify novel biomarker signatures and spatial patterns invisible to the human eye to better understand drug mechanism of action.
Flexible configurations
Easy deployment
19+ IMS partners
Our Partners Include
Biomarker Training:
Scale Expertise Globally
The Challenge: New biomarkers require specialized knowledge. Inconsistent interpretation by local pathologists can lead to under-diagnosis and lost market share.
Standardize Global Adoption
Empower the medical community with a digital masterclass platform designed to train pathologists on your biomarkers using AI-assisted trainings. Ensure that every pathologist, regardless of location, can accurately identify the patients who will benefit most from your therapy.
peakAcademy is already actively supporting biomarker training programs with biopharma across more than 20 countries.
Real-time progress monitoring
Instant results analysis
Seamless data export
24
diagnostic algorithms
(11 CE-marked)
40+
Lab installations worldwide
19
clinical IMS partner integrations
40+
Publications
Partner for Precision
Mindpeak technology, complemented by a dedicated 50+ expert team based in Hamburg and Boston, and through reproducible, scalable AI-tissue biomarkers is turning uncertainty into informed decision-making for therapy success.
